Approved Study Database

Ref. No. Scientific Title Principal investigator
2024.145 Foundation Models-Empowered Ambient Intelligence Systems for Early Diagnosis, Personalized Intervention, and Complex Cross-Disease Interplay Analysis of Aging Related Degenerative Diseases Prof. XING Guoliang
邢國良
2024.146 The efficacy and cost-effectiveness of a deep-learning system for supporting diabetic macular edema triage screening: a randomised controlled trial Dr. HO Mary
2024.148 The conflict status of fertility preservation decision-making and their impacts on decision results in childbearing-age female patients with cancer Prof. CHAN Carmen W.H.
2024.138 Personalized Rehabilitation Pathways to Maximal Motor Functional Return through an AI Recovery Prediction System for Diverse Stroke Survivors Prof. CHEUNG Vincent Chi Kwan
張智鈞
2024.144 Virtual Reality assisted Fitness for Fun (FF) intervention optimizes health and reduces cost of illness in Hong Kong older adults with mild neurocognitive disorders – a pragmatic trial Prof. LAM Linda Chiu Wa
2024.142 Machine learning and prediction of major adverse cardiovascular events in patients prescribed second-generation antipsychotics - a territory-wide study Dr. CHAN Joey Wing Yan
2024.134 Optimal Dosage of Atropine and Red Light Combination Therapy for Myopia Treatment (LAMP-4) Study Dr. YAM Jason Cheuk Sing
2024.154 Empirical development of Standard Operation Procedures guiding nursing practice in specialties of Chinese medicine [本港中醫護理分科標準作業程序製訂研究] Prof. CHAIR Sek Ying
2024.160 Video Analysis for Automated Surgical Skill Assessment in Cataract Surgery Prof. CHENG Shing Shin
2024.126 Effect of computerized cognitive training in dementia with depression: a pilot randomized controlled trial Dr. LEE Allen Ting Chun
Allen Ting Chun Lee
2024.128 Development of Building Respectful Online Space (BROS) Intervention for preventing cyberbully in Adolescents: A Qualitative Study Ms. SHI Yu
時豫
2024.129 Repeated Low-level Red Light for Myopia Progression Study: An International, Multicenter, Multiethnic, Randomized Controlled Trial, IPOSC Study Dr. YAM Jason Cheuk Sing
2024.114 Surveys to investigate injection site complications and pain related to androgen deprivation therapies in prostate cancer patients Prof. NG Chi Fai
吳志輝
2024.109 Determinants of event-free survival and late reintervention after the Bentall procedure: A single-centre retrospective study Prof. WONG Randolph Hung Leung
黃鴻亮
2024.110 Determinants of early and late survival after surgery for cardiac tumours Prof. WONG Randolph Hung Leung
黃鴻亮
2024.118 Epidemiology of Acute Sports Injuries in Hong Kong Elite Fencing Athletes Prof. YUNG Patrick Shu Hang
容樹恒
2024.113 Multi-center Evaluation of Alpha-thalassaemia Early Eluting Peak, Immunochromatographic Strip Test and Haemoglobin H Inclusion Test for Alpha-thalassaemia Screening Dr. YUEN Carmen Michelle
2024.162 Prevalence of Immune-Mediated Inflammatory Diseases (IMIDs) among the post-Coronavirus Disease 2019 (COVID-19) infection population Dr. ZHANG Lin
2024.115 Behavior, Aspirations and Treatment needs of people living with hepatitis B Professor Wong Lai Hung Grace
2024.098 Establishment of a Hepatocellular Carcinoma Database Prof Chan Lam Stephen
2024.096 An Open-label, Randomized Phase 3 Study of MK-2870 as a Single Agent and in Combination with Pembrolizumab Versus Treatment of Physician’s Choice in Participants with HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer Prof. YEO Winnie
2024.089 Open and closed platform robotic-assisted versus conventional total knee arthroplasty: a randomised controlled trial Prof. ONG Michael Tim Yun
2024.101 Functional Impact of Joint-line Obliquity and Left-right Symmetry in Patients with Oxford Unicompartmental Knee Arthroplasty Dr. LO Kelvin Chin Hei
2024.085 Investigating the association between circulating metabolome and blood-brain barrier leakage in cerebral small vessel disease Dr. Lam Bonnie Yin Ka
2024.084 Validation of the Chinese Fall Efficacy Scale (FES) Ms. LI Pui Man
2024.100 Evaluation of long-term effectiveness and cost-effectiveness of SGLT2-i and risk-based treatment strategies for primary prevention of cardiovascular-renal events in patients with type-2 diabetes utilizing a Chinese individual-patient simulation model Dr. LUI Juliana Nga Man
呂雅文
2024.090 Empagliflozin on Residual Kidney Function in Incident Peritoneal Dialysis Patients: a Pilot Randomized Controlled Trial (EMPIRIC-PD trial) Dr. NG Jack Kit Chung
2024.093 A Double-Blind, Randomized, Placebo-Controlled, Multicentre Study Evaluating the Efficacy and Safety of Baxdrostat in Asian Participants with Uncontrolled Hypertension on Two or More Medications including Participants with Resistant Hypertension (BaxAsia) Prof. TAN Guangming
譚廣明
2024.094 A Phase 3, Randomized Study Evaluating the Efficacy and Safety of TAR-210 Erdafitinib Intravesical Delivery System Versus Single Agent Intravesical Chemotherapy in Participants With Intermediate-risk Non-muscle Invasive Bladder Cancer (IR-NMIBC) and Susceptible FGFR Alterations Prof. TEOH Jeremy Yuen Chun
2024.105 Development of a Biobank for Studying the Pathogenesis and Treatment of Musculoskeletal Disorders Prof. LUI Po Yee Pauline
呂寶儀
2024.078 Evaluation of an Artificial Intelligence chatbot for sleep education Dr. LI Man Ho
2024.081 Validation of 4ATs score Chinese version in patients underwent abdominal surgery for detection of post-operative delirium Dr. LAU Ruby Siu Ting
劉肇庭
2024.079 Ultrasonography of the Distal Radioulnar Joint Translation: With and Without Activation of Proximal Upper Limb Muscles in Triangular Fibrocartilage Complex Injury Dr. WONG Clara Wing Yee
2024.092 Effect of repetitive Transcranial Magnetic Stimulation (rTMS) on serum brain derived neurotrophic factor (BDNF) and serum neutrophil-lymphocyte ratio (NLR) in treatment-resistant depression (TRD) patients and its correlation with clinical treatment response Dr. LAM Lydia Yi Ngar
林薾雅
2024.106 Phase 1 randomised controlled clinical trial testing the safety and efficacy of CPP-anti-VEGF for the treatment of neovascular age-related macular degeneration Dr. BRELEN Mårten Erik
2024.087 A Prospective Study of Stool Microbiome Biomarkers for Early Detection and Risk Prediction of Autism Spectrum Disorder in Toddlers (PROMISE-Tod) Dr. WONG Wing Ho Oscar
2024.082 Barriers and facilitators to preconception care of obese women in reproductive age in Hong Kong: a qualitative study Dr. LAU Hoi Ki
2024.080 The Effect of Implementing an Electronic Surgical Counting System on the Surgical Counting Process Mr. NGAN Hoi Tik
2024.086 Circadian Regulation in Children with Obstructive Sleep Apnoea Dr. CHAN Ching Ching
陳晶晶
2024.107 The effect of Short Message Service interventions on promoting exercise adherence for patients with knee conditions Prof. ONG Michael Tim-Yun
Michael Tim-Yun ONG
2024.076 Epidemiological trends of Paediatric inflammatory bowel disease in Hong Kong: A single center analysis of 17 year data Dr CHIU Chi Ying Jaime
2024.075 Dyadic video-assisted gamified group-based music breathing therapy on enhancing resilience among children with attention-deficit hyperactivity disorder and their caregivers: A pilot randomized controlled trial Dr. CHEUNG Tan
2024.102 Deciphering the association between HPV oncoproteins and Polo-like Kinase 1 Dr. BOON Siaw Shi
Siaw Shi Boon
2024.072 A retrospective study to examine risk factors and clinical outcomes of Escherichia coli bacteremia Prof. NG Wai Yin
2024.095 A Phase 1b/2, Open-Label, Dose Escalation and Expansion Study of ADG126 in Combination with Pembrolizumab (Anti-PD-1 Antibody) in Patients with Advanced/Metastatic Solid Tumors Prof. MA Brigette Buig Yue
2024.091 Using social norms to promote physical activity among physically inactive college students in China: A randomized controlled trial Mr. YE Xinchen
叶欣晨
2024.068 Developing and evaluating a retrieval practice unified neural network model Dr. LIU Xiaonan
2024.071 Radiological Imaging of Non-Accidental Injury in Paediatric Patients Dr Young Yee Man Catherine
楊綺文
2024.067 AI-powered Multimodality approach to screen and diagnose Thoracic Aortic Aneurysm and Dissection (TAAD) Prof. WONG Randolph Hung Leung
黃鴻亮
2024.063 NRG-HN011: A RANDOMIZED PHASE II STUDY OF NIVOLUMAB VERSUS NIVOLUMAB AND BMS-986016 (RELATLIMAB) AS MAINTENANCE TREATMENT AFTER FIRST-LINE TREATMENT WITH PLATINUM-GEMCITABINE-NIVOLUMAB FOR PATIENTS WITH EPSTEIN-BARR VIRUS-ASSOCIATED RECURRENT/METASTATIC NASOPHARYNGEAL CARCINOMA (REMAIN) Prof. MA Buig-Yue, Brigette

Page 1 of 248.